MSK L15 Osteoporosis Flashcards
Bone structure:
- Cortical bone → compact outershel (bone strength)
- Trabecular bone → network of interconnecting plates →
a. Strength
b. Surface for exchange of calcium
c. Physical template for haemopoiesis
Macroarchitecture and bone strength:
- Bone strength
a. Cross sectional area → large resistance ot bending
b. Cortical thickness - Bone shape
a. Hip axis length →
Microarchitecture and bone strength
Trabecular bone: 1. Trabecular thickness 2. Trabecular number 3. Trabecular connectivity Cortical bone 1. Cortical thickness 2. Cortical porosity
Connectedness of trabeculae → Eular
Eular Buckling Theory
See image 112 – organisatino of plates important in strength
Fibrils →
→ hydroxyapatitie crystals – resistance to compression
Organic phase →
type 1 collagen and other non-collagenous proteins e.g. osteocalcin → tensile strength
Section 2: Bone remodelling
- Lifelong process involving discrete sites throughout the while skeleton
- Each remodelling cycle takes 3-4 months to complete
- Ensures readily available supply of calcium for calcium homeostasis
- Maintains bone integrity by replacing sites of fatigue damage
Bone Formation
- Mechanical Loading
- Androgens
- Intermittent PTH
- B-blockers
Bone resorption
- Oestrogen defiency
- Immobilization
Low Ca
Osteoblasts action
→ Pump protons that activated enzymes → TRAP and CATK
Osteoclasts Formed from
mononucleur precursors shared with monocytes then a number of factors drive the mononuclear precursors down osteoclast pathway.
Osteoclasts Stimulation of formation
Cytokines → RANKL (produced by stromal cells in bone marrow) interact with RANK receptor = stimulation and formation of mature osteoclasts.
OPG →
Block RANKL
Denosumab →
RANK ligand inhibitor for postmenopausal women = osteoporosis treatment
Osteoblasts: Found
Sit on the surface of trabecular bone synthesis
Osteoblasts:Mesenchyme precursor →
Produce myoblasts (muscle), adipocytes(fat) chondrocytes(cartilage) and osteoblasts (bone).
Osteoblasts: LRP5/Wnt signlaiing pathway
Stimulates osteoblasts formation
Osteoblasts: A mutation in LRP5
Constant activation of pathway → excess bone density in hip and spine
Osteoblasts: Sclerostin
Secreted by osteocytes, which inhibits bone formation. Strain on bone switches this off.
Osteoblasts:Sclerostin defiency
Causes a high bone mass phenotype
• Enlarged mandibles
• Facial nerve palsys due to overgrowth of skull in IAM
Sclerostin antibody
Osteoporosis treatment
Epi
osteoporosis
More common in women
Fractures most common with age and in hip, vertebrae, colles’ (distal radius)
Bone remodelling in osteoporosis
Imbalance – amount of resorption exceeds formation
Oestrogen related
Osteoporosis measure in
DXA
Peak bone mass
Diet
Exercise
Genes
Bone loss
Low calcium/vitamin d Immobility Genes Estrogen defiency Steroids
Vertebral Fracture
- Kyphoctic deformity
- Height loss
- Increased backpain
- Decreased activity
- Impaired quality of life
- Increased mortality
- Increased risk of vertebral and non-vertebral fractures
Bone remodelling and osteoporosis: Trabecular Bone:
- Increased activation frequency
- Increased erosion depth
- Reduced trabecular thickenss
Bone remodelling and osteoporosis: Cortical Bone
Structural changes also effect cortical bone, characterised by endosteal expansion, cortical thinning, and an increase in size and number of Haversian canals.
Expansino of endosteal surface, thinning and weakening
Treatments:
Anti-resorptive
Mixed action
Anabolic
Anti-resorptive
Bisphosphonates → alendronate, risedronate, Ibandronate
Denosumab → RANK ligand inhibitor for postmenopausal women = osteoporosis treatment → more potnet thatn aldrenodate (knocks out osteoclast)
Mixed action
Strontium → act as a combination of stimulating osteobalsta and inhibiting osteoclasts
Anabolic
PTH → teriparatide (PTH1-34), Preotact (PTH 1-84)
Bisphosphonates → Treatment for
- Osteoporosis
- Pagets → a particular sites in skeleton get overgrowth of osteoglasts = expansion of bone and bone pain
- Hypercalcaemia malignancy → secondary depositis in skeleton → stimulatin of osteoclasts, resorption and hypercalcaemia.
Bisphosphonates → Chemical structure
Retained in bone as they bind in bone as they bind the crystals
Strontium ranelate →
heavily metal salt that is retained within bone, which stimulates formation and inhibits resorption